id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-E-0027-0020,FDA,FDA-2001-E-0027,Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ANGIOMAX,Notice,N-Notice,2010-12-16T05:00:00Z,2010,12,2010-12-16T05:00:00Z,,2024-11-12T05:00:23Z,2010-31583,1,0,0900006480bb825a
FDA-2001-E-0027-0019,FDA,FDA-2001-E-0027,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-11-24T05:00:00Z,2010,11,2010-11-24T05:00:00Z,,2010-11-24T13:39:34Z,,0,0,0900006480ba28ee
FDA-2001-E-0027-0018,FDA,FDA-2001-E-0027,U.S. Patent & Trademark Office to Wilmer Cutler Pickering Hale and Dorr LLP - Letter,Other,LET-Letter,2010-09-14T04:00:00Z,2010,9,2010-09-14T04:00:00Z,,2013-07-27T23:30:50Z,,0,0,0900006480b4edf1
FDA-2001-E-0027-0017,FDA,FDA-2001-E-0027,US Patent and Trademark Office to Wilmer Cutler Pickering Hale and Dorr LLP - Denial of Application,Other,ADN-Denial of Application,2010-04-01T04:00:00Z,2010,4,,,2013-08-11T01:33:32Z,,0,0,0900006480acd82c
FDA-2001-E-0027-0016,FDA,FDA-2001-E-0027,"The Medicines Company v. USPTO, FDA, and DHHS, No. 1:10cv81-CMH/TCB, in the United States District Court for the Eastern District of Virginia (Alexandria Division), January 27, 2010 - Background Material",Supporting & Related Material,BKG-Background Material,2010-02-16T05:00:00Z,2010,2,,,2010-04-01T13:04:43Z,,0,0,0900006480aa5857
FDA-2001-E-0027-0015,FDA,FDA-2001-E-0027,"U.S. Patent & Trademark Office to The Medicine Company, November 20, 2001 re Notice of Final Determination  - Letter",Other,CP-Citizen Petition,2010-02-02T05:00:00Z,2010,2,,,2013-07-27T23:05:51Z,,0,0,0900006480a8ba8a
FDA-2001-E-0027-0012,FDA,FDA-2001-E-0027,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-02-01T05:00:00Z,2010,2,2010-02-01T05:00:00Z,,2013-08-11T03:06:37Z,,0,0,0900006480a88cb0
FDA-2001-E-0027-0011,FDA,FDA-2001-E-0027,The Medicines Company (Fish & Neave) - Application for Patent Extension Term,Other,APP-Application,2010-02-01T05:00:00Z,2010,2,2010-02-01T05:00:00Z,,2013-07-27T21:00:00Z,,0,0,09000064804b5c99
FDA-2001-E-0027-0014,FDA,FDA-2001-E-0027,"U.S. Patent & Trademark Office to The Medicine Company, March 2, 2002 re Corrected Notice of Final Determination - Letter",Other,LET-Letter,2010-02-01T05:00:00Z,2010,2,2010-02-01T05:00:00Z,,2013-07-27T23:05:43Z,,0,0,0900006480a88ef2
FDA-2001-E-0027-0013,FDA,FDA-2001-E-0027,"Blank Rome, LLP to FDA/CDER - Letter",Other,LET-Letter,2010-02-01T05:00:00Z,2010,2,2010-02-01T05:00:00Z,,2013-07-27T23:05:43Z,,0,0,0900006480a88cb3